292 related articles for article (PubMed ID: 15058150)
1. Statins for primary and secondary prevention of coronary heart disease. A scientific review.
Carneiro AV; Costa J; Borges M
Rev Port Cardiol; 2004 Jan; 23(1):95-122. PubMed ID: 15058150
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease.
Marchioli R; Marfisi RM; Carinci F; Tognoni G
Arch Intern Med; 1996 Jun; 156(11):1158-72. PubMed ID: 8639010
[TBL] [Abstract][Full Text] [Related]
3. Lipid lowering agents. How important are they in secondary prevention of coronary heart disease?
Colquhoun DM
Aust Fam Physician; 2002 Jan; 31(1):25-6, 29-30. PubMed ID: 11840884
[TBL] [Abstract][Full Text] [Related]
4. [Statins in secondary prevention of coronary heart disease].
Sandhofer F
Wien Med Wochenschr; 1999; 149(5-6):125-8. PubMed ID: 10408003
[TBL] [Abstract][Full Text] [Related]
5. Lipid-lowering update 2001. Aggressive new goals.
Fenske TK
Can Fam Physician; 2001 Feb; 47():303-9. PubMed ID: 11228031
[TBL] [Abstract][Full Text] [Related]
6. Statins for stroke prevention: disappointment and hope.
Amarenco P; Tonkin AM
Circulation; 2004 Jun; 109(23 Suppl 1):III44-9. PubMed ID: 15198966
[TBL] [Abstract][Full Text] [Related]
7. Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence.
Preiss D; Sattar N
Clin Endocrinol (Oxf); 2009 Jun; 70(6):815-28. PubMed ID: 19067719
[TBL] [Abstract][Full Text] [Related]
8. Primary prevention of coronary heart disease in the elderly.
Dornbrook-Lavender KA; Pieper JA; Roth MT
Ann Pharmacother; 2003 Nov; 37(11):1654-63. PubMed ID: 14565805
[TBL] [Abstract][Full Text] [Related]
9. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.
Chapman MJ; Assmann G; Fruchart JC; Shepherd J; Sirtori C;
Curr Med Res Opin; 2004 Aug; 20(8):1253-68. PubMed ID: 15324528
[TBL] [Abstract][Full Text] [Related]
10. The benefits of reducing cholesterol levels: the need to distinguish primary from secondary prevention. 1. A meta-analysis of cholesterol-lowering trials.
Silberberg JS; Henry DA
Med J Aust; 1991 Nov; 155(10):665-6, 669-70. PubMed ID: 1834922
[TBL] [Abstract][Full Text] [Related]
11. Statin therapy in the primary and secondary prevention of coronary artery disease in patients with type 2 diabetes. A scientific review.
Paulo S; Fernandes S; Vizinho R; Carneiro AV
Rev Port Cardiol; 2004 Nov; 23(11):1461-82. PubMed ID: 15693698
[TBL] [Abstract][Full Text] [Related]
12. [All mortality by cause of death. The challenge of coronary prevention].
Fernández-Cruz A
Rev Esp Cardiol; 1998; 51 Suppl 6():23-9. PubMed ID: 10050141
[TBL] [Abstract][Full Text] [Related]
13. Controversies in primary prevention among hyperlipidemic patients.
McPherson R
Can J Cardiol; 1999 Apr; 15 Suppl B():16B-19B. PubMed ID: 10350678
[TBL] [Abstract][Full Text] [Related]
14. [Hypercholesterolemia: to treat or not to treat? That is the question].
Ducobu J
Rev Med Brux; 1994; 15(3):124-31. PubMed ID: 8066357
[TBL] [Abstract][Full Text] [Related]
15. [New results in the management of hypercholesterolemia].
Sármán B
Orv Hetil; 2005 Sep; 146(39):1999-2004. PubMed ID: 16265867
[TBL] [Abstract][Full Text] [Related]
16. Prevention of mortality from coronary heart disease with pravastatin.
Tonkin AM; Ryan EW
Biomed Pharmacother; 1999 Oct; 53(9):405-8. PubMed ID: 10554675
[TBL] [Abstract][Full Text] [Related]
17. [Statins and stroke].
Chudzik W; Kaczorowska B; Chmielewski H; Przybyła M; Gałka M
Pol Merkur Lekarski; 2005 Oct; 19(112):591-5. PubMed ID: 16379334
[TBL] [Abstract][Full Text] [Related]
18. Statins in the prevention of coronary heart disease.
Williamson DR; Pharand C
Pharmacotherapy; 1998; 18(2):242-54. PubMed ID: 9545143
[TBL] [Abstract][Full Text] [Related]
19. [The effects of statins on stroke and cardiovascular incidence in randomized, placebo-controlled trials with clinical endpoints].
Márk L; Katona A
Orv Hetil; 2000 Jul; 141(27):1501-5. PubMed ID: 10943107
[TBL] [Abstract][Full Text] [Related]
20. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
